Head and Neck Cancer |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 3 |
2 |
1 |
34 |
CNS Tumors |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 1 - Bioequivalence Study |
1 |
2 |
17 |
Urologic Tumors |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 1 - Medical Device Study |
2 |
1 |
10 |
Chemotherapy Induced Nausea |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 3 |
2 |
7 |
130 |
Oncohaematologic diseases |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 1 |
1 |
2 |
2 |
Phase 2 |
1 |
3 |
15 |
Phase 3 |
1 |
2 |
19 |
Gastrointestinal Tumors |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 2 |
2 |
2 |
9 |
Phase 1 - Bioequivalence Study |
4 |
5 |
48 |
Colorectal Cancer |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
First Phase - Bioequivalence |
4 |
5 |
48 |
Lung Cancer |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 2 |
3 |
2 |
28 |
Breast Cancer |
Number of Trials |
Number of Clinics |
Number of Patients |
|---|---|---|---|
Phase 3 |
2 |
4 |
38 |
Phase 2 |
2 |
4 |
56 |
Phase 1 |
2 |
2 |
36 |
Phase 1 - Bioequivalence Study |
4 |
7 |
86 |